PrEP goes local: Community-Based HIV prevention trial launches in rio
NCT ID NCT07584122
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to make HIV prevention easier to access for underserved groups in Rio de Janeiro, such as gay and bisexual men, transgender women, and sex workers. Instead of requiring clinic visits, participants can get daily PrEP pills and support through community organizations, mobile units, or telehealth. Researchers will see if this approach helps more people start and stay on PrEP, with the goal of reducing new HIV infections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC) oral PrEP
What this could lead to
If successful, this could show that offering PrEP in community settings helps more at-risk people start and stay on HIV prevention, reducing new infections in underserved areas.
What could go wrong
This is an early feasibility study with 400 participants, so results may not apply broadly. Daily pill adherence can be challenging, and the study does not directly measure HIV infection rates.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Geral de Nova Iguaçu
RECRUITINGNova Iguaçu, Rio de Janeiro, 26030-380, Brazil
Contact Email: •••••@•••••
-
Instituto Nacional de Infectologia Evandro Chagas
RECRUITINGRio de Janeiro, Rio de Janeiro, 21040360, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••